STS/EACTS: Important Trials Every Surgeon Should Know About

Moderator(s)

• 

  Vinod Thourani, MD

  Marcus Chairman of Cardiovascular Surgery
  Piedmont Heart Institute and Piedmont Healthcare
  Atlanta, Georgia, United States
• 

  Patrick Myers, MD (he/him/his)

  Cardiac Surgeon
  CHUV
  Geneva University Medical School
  Lausanne, Switzerland

Presentations:

• 9:00 AM – 9:10 AM CT

  The 5 Year Results of PARTNER 3 Favor More SAVR in Low-Risk Patients
  

  Invited Speaker: Michael Mack, MD – Baylor Scott & White Health
• 9:10 AM – 9:20 AM CT

  The 5 Year Results of PARTNER 3 Favor More TAVR in Low-Risk Patients
  

  Invited Speaker: Gry Dahle, MD, PhD (she/her/hers) – Oslo University Hospital
• 9:20 AM – 9:30 AM CT

  Audience Q&A
• 9:30 AM – 9:40 AM CT

  Transcatheter Tricuspid Valve Replacement: Obtaining the Necessary Skills for Success
  

  Invited Speaker: James Stewart, MD, FACC – Piedmont Heart Institute
• 9:40 AM – 9:50 AM CT

  Transcatheter Tricuspid Valve Repair: Is This the New Gold Standard Instead of Surgical Repair?
  

  Invited Speaker: Gorav Ailawadi, MD, MBA – University of Michigan
• 9:50 AM – 10:00 AM CT

  Audience Q&A
• 10:00 AM – 10:10 AM CT

  Hybrid and Surgical AF Ablation: What the Surgeons Need to Know
  

  Invited Speaker: Patrick Myers, MD (he/him/his) – CHUV
• 10:10 AM – 10:15 AM CT

  Audience Q&A
• 10:15 AM – 10:25 AM CT

  Randomized Trials by Surgeons for Surgeons: CTSN
  

  Invited Speaker: Annetine Gelijns, PhD – Icahn School of Medicine at Mount Sinai
• 10:25 AM – 10:30 AM CT

  Audience Q&A